Dormancy of Solitary Metastatic Cells

After arriving in a secondary site metastatic cells either begin proliferating, undergo apoptosis or remain as solitary dormant cells. The process of metastasis, although dangerous, is extremely inefficient with the majority of the cells undergoing apoptosis and thus becoming clinically irrelevant. Of the cells that begin proliferating, the few that make it past the micrometastasis stage may be of immediate clinical relevance. Dormant cells, while not of immediate clinical concern, are believed to be at least in part responsible for cancer recurrence that can occur decades after apparently successful initial treatment. Dormant solitary cells are different from “dormant” micrometastases, in which active proliferation is balanced by apoptosis. The mechanisms of cell cycle regulation and the function of the molecules regulating this process are well understood. However, there is relatively little known about the mechanisms controlling cell cycle regulation and dormancy of solitary metastatic cells. There are several inherent difficulties impeding the study of solitary cells. This review paper will examine the models used in the study of dormant solitary metastatic cells, methods of imaging and studying these cells, the molecular mechanisms believed to be responsible for solitary cell dormancy, and finally the unique treatment challenges posed by these cells.

[1]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[2]  Hedi Mattoussi,et al.  Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.

[3]  J. Massagué,et al.  G1 cell-cycle control and cancer , 2004, Nature.

[4]  R. Demicheli,et al.  Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[6]  Jason L. Townson,et al.  The role of apoptosis in tumor progression and metastasis. , 2003, Current molecular medicine.

[7]  François Malecaze,et al.  Opposite long-term regulation of c-Myc and p27Kip1 through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells , 2003, Oncogene.

[8]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[9]  J. Aguirre Ghiso Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.

[10]  I. Macdonald,et al.  Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth , 1994, Clinical & Experimental Metastasis.

[11]  S. Kondo,et al.  Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. , 2006, Journal of dermatological science.

[12]  G. Schwartz,et al.  Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. , 2003, Molecular cancer therapeutics.

[13]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[14]  G. Wahl,et al.  Cellular Dynamics Visualized in Live Cells in Vitro and in Vivo by Differential Dual-Color Nuclear-Cytoplasmic Fluorescent-Protein Expression , 2004, Cancer Research.

[15]  M. Malumbres,et al.  Cell cycle deregulation: a common motif in cancer. , 2003, Progress in cell cycle research.

[16]  G. Naumov,et al.  Solitary cancer cells as a possible source of tumour dormancy? , 2001, Seminars in cancer biology.

[17]  I. Macdonald,et al.  Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. , 2000, Cancer research.

[18]  Kwang Il Kim,et al.  In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27. , 2006, Cancer research.

[19]  J. Gabrilove,et al.  The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. , 1997, Blood.

[20]  V. Morris,et al.  Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines , 2004, Clinical & Experimental Metastasis.

[21]  J. Uhr,et al.  Cancer dormancy and cell signaling: induction of p21(waf1) initiated by membrane IgM engagement increases survival of B lymphoma cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Paules,et al.  DNA damage and cell cycle checkpoints , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  A. Murray,et al.  Recycling the Cell Cycle Cyclins Revisited , 2004, Cell.

[24]  W. Falk,et al.  A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. , 2001, Cancer research.

[25]  Mina J Bissell,et al.  Modeling tissue-specific signaling and organ function in three dimensions , 2003, Journal of Cell Science.

[26]  M. Gonen,et al.  The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates γ-Irradiation-Induced Apoptosis in Colon and Gastric Cancer Cells , 2003 .

[27]  I. D'Agnano,et al.  Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27kip1 levels , 2001, Oncogene.

[28]  R. Demicheli,et al.  Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of ‘cures’ , 1999, Breast Cancer Research and Treatment.

[29]  F. Ciardiello,et al.  p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate , 2006, Journal of surgical oncology.

[30]  J. Aguirre-Ghiso,et al.  ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK , 2003 .

[31]  G. Pruneri,et al.  Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Yasuo Watanabe,et al.  Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. , 2006, Oncology reports.

[33]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[34]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[35]  L. Ossowski,et al.  Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling , 1999, The Journal of cell biology.

[36]  E. Sausville,et al.  Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. , 1996, Cancer research.

[37]  J. Ghiso Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.

[38]  Meng Yang,et al.  Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. , 2002, Cancer research.

[39]  E. Sausville,et al.  Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. , 1999, Cancer research.

[40]  David Zurakowski,et al.  A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. , 2006, Journal of the National Cancer Institute.

[41]  L. Weiss Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells. , 1996, Cancer treatment and research.

[42]  Wei Yan,et al.  Effect of p27(KIP1) on cell cycle and apoptosis in gastric cancer cells. , 2005, World journal of gastroenterology.

[43]  G. Lozano,et al.  Differential roles of p21(Waf1) and p27(Kip1) in modulating chemosensitivity and their possible application in drug discovery studies. , 2001, Molecular pharmacology.

[44]  M. Gonen,et al.  The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  G. Naumov,et al.  Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. , 2002, Cancer research.

[46]  Jason L. Townson,et al.  Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases , 2003, Breast Cancer Research and Treatment.

[47]  I. Macdonald,et al.  Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis , 1993, Clinical & Experimental Metastasis.

[48]  R. Scheuermann,et al.  Cancer dormancy: role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM. , 1998, Cancer research.

[49]  Chris Heyn,et al.  In vivo magnetic resonance imaging of single cells in mouse brain with optical validation , 2006, Magnetic resonance in medicine.

[50]  D. McDonald,et al.  Cellular abnormalities of blood vessels as targets in cancer. , 2005, Current opinion in genetics & development.

[51]  Sanjiv S Gambhir,et al.  Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.

[52]  L. Ossowski,et al.  Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy , 1997, The Journal of cell biology.

[53]  S. Nie,et al.  Quantum dot nanocrystals for in vivo molecular and cellular imaging. , 2004, Photochemistry and photobiology.

[54]  T. Fujimori,et al.  Vesnarinone: a differentiation-inducing anti-cancer drug , 2003, Anti-cancer drugs.

[55]  J. Mendelsohn,et al.  Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1 , 2000, Oncogene.

[56]  R. Demicheli,et al.  Tumour dormancy: findings and hypotheses from clinical research on breast cancer. , 2001, Seminars in cancer biology.

[57]  Y. Kudo,et al.  Small interfering RNA targeting of S phase kinase–interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation , 2005, Molecular Cancer Therapeutics.

[58]  H. Drexler The role of p27Kip1 in proteasome inhibitor induced apoptosis. , 2003, Cell cycle.

[59]  A. Chambers,et al.  Therapeutic targets for antimetastatic therapy , 2004, Expert opinion on therapeutic targets.

[60]  A. Margulis,et al.  Loss of intercellular adhesion activates a transition from low‐ to high‐grade human squamous cell carcinoma , 2006, International journal of cancer.

[61]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[62]  J. Aguirre-Ghiso,et al.  Green Fluorescent Protein Tagging of Extracellular Signal-Regulated Kinase and p38 Pathways Reveals Novel Dynamics of Pathway Activation during Primary and Metastatic Growth , 2004, Cancer Research.

[63]  J. Aguirre-Ghiso,et al.  Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. , 2001, Molecular biology of the cell.

[64]  Z. Fan,et al.  Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells , 2001, Oncogene.

[65]  J. Tobias,et al.  Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies. , 2005, Cancer research.

[66]  M. Nakanishi,et al.  p27Kip 1 Expression by Contact Inhibition as a Prognostic Index of Human Glioma , 2000, Journal of neurochemistry.

[67]  Kathryn Sharer,et al.  In vivo detection of single cells by MRI , 2006, Magnetic resonance in medicine.

[68]  H. Endo,et al.  Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area. , 2006, Cancer research.

[69]  Christopher H. Contag,et al.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.

[70]  G. Naumov,et al.  Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. , 1999, Journal of cell science.

[71]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[72]  S. Goodison,et al.  Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[73]  J. Folkman,et al.  Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. , 1998, The Journal of clinical investigation.

[74]  J. Aguirre-Ghiso,et al.  Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. , 2006, Cancer research.

[75]  Akiyoshi Hoshino,et al.  Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. , 2004, Biochemical and biophysical research communications.

[76]  Y. Kudo,et al.  Transfection of p27Kip1 Threonine Residue 187 Mutant Type Gene, Which Is Not Influenced by Ubiquitin-Mediated Degradation, Induces Cell Cycle Arrest in Oral Squamous Cell Carcinoma Cells , 2002, Oncology.

[77]  M. Abdellatif,et al.  Flavopiridol Blocks Integrin-Mediated Survival in Dormant Breast Cancer Cells , 2005, Clinical Cancer Research.

[78]  G. Schwartz,et al.  Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells. , 2002, Cancer research.

[79]  J. Harper,et al.  The mammalian cell cycle: an overview. , 2005, Methods in molecular biology.

[80]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[81]  J. Aguirre-Ghiso,et al.  ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). , 2003, Cancer research.

[82]  G. Naumov,et al.  Critical steps in hematogenous metastasis: an overview. , 2001, Surgical oncology clinics of North America.

[83]  M. Gonen,et al.  Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[84]  D. McEachern,et al.  Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia. , 1992, British Journal of Cancer.

[85]  G. Pruneri,et al.  Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review. , 2005, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[86]  H. Shimada,et al.  Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[87]  I. Macdonald,et al.  Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos studied by high-resolution intravital videomicroscopy. , 1992, Journal of the National Cancer Institute.

[88]  M. McMahon,et al.  Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. , 2005, Cancer research.

[89]  J. Funk,et al.  Linking DNA Damage to Cell Cycle Checkpoints , 2002, Cell cycle.

[90]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[91]  A. Tomkinson,et al.  DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis , 1999, Oncogene.

[92]  W. Yu,et al.  The role of plasminogen activator receptor in cancer invasion and dormancy. , 1999, Medicina.

[93]  Mina J Bissell,et al.  Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.

[94]  G. Pruneri,et al.  Prognostic Significance of P27 and Cyclin D1 Co-Expression in Laryngeal Squamous Cell Carcinoma: Possible Target for Novel Therapeutic Strategies , 2004, Journal of chemotherapy.

[95]  Mina J Bissell,et al.  The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.